241 related articles for article (PubMed ID: 30439595)
1. A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases.
Smith AR; Smith RG; Burrage J; Troakes C; Al-Sarraj S; Kalaria RN; Sloan C; Robinson AC; Mill J; Lunnon K
Neurobiol Aging; 2019 Feb; 74():70-76. PubMed ID: 30439595
[TBL] [Abstract][Full Text] [Related]
2. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease.
Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K
Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171
[TBL] [Abstract][Full Text] [Related]
3. The histone modification H3K4me3 is altered at the
Smith AR; Smith RG; Macdonald R; Marzi SJ; Burrage J; Troakes C; Al-Sarraj S; Mill J; Lunnon K
Future Sci OA; 2021 Feb; 7(4):FSO665. PubMed ID: 33815817
[TBL] [Abstract][Full Text] [Related]
4. Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain.
Scholefield M; Church SJ; Xu J; Patassini S; Cooper GJS
J Parkinsons Dis; 2024 May; ():. PubMed ID: 38820022
[TBL] [Abstract][Full Text] [Related]
5. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease.
Lunnon K; Smith R; Hannon E; De Jager PL; Srivastava G; Volta M; Troakes C; Al-Sarraj S; Burrage J; Macdonald R; Condliffe D; Harries LW; Katsel P; Haroutunian V; Kaminsky Z; Joachim C; Powell J; Lovestone S; Bennett DA; Schalkwyk LC; Mill J
Nat Neurosci; 2014 Sep; 17(9):1164-70. PubMed ID: 25129077
[TBL] [Abstract][Full Text] [Related]
6. Human dementia with Lewy bodies brain shows widespread urea elevations.
Scholefield M; Church SJ; Philbert S; Xu J; Patassini S; Cooper GJS
Parkinsonism Relat Disord; 2024 Jul; 124():107017. PubMed ID: 38788611
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci.
De Jager PL; Srivastava G; Lunnon K; Burgess J; Schalkwyk LC; Yu L; Eaton ML; Keenan BT; Ernst J; McCabe C; Tang A; Raj T; Replogle J; Brodeur W; Gabriel S; Chai HS; Younkin C; Younkin SG; Zou F; Szyf M; Epstein CB; Schneider JA; Bernstein BE; Meissner A; Ertekin-Taner N; Chibnik LB; Kellis M; Mill J; Bennett DA
Nat Neurosci; 2014 Sep; 17(9):1156-63. PubMed ID: 25129075
[TBL] [Abstract][Full Text] [Related]
8. Anhedonia in Neurodegenerative Diseases.
Turner V; Husain M
Curr Top Behav Neurosci; 2022; 58():255-277. PubMed ID: 35435648
[TBL] [Abstract][Full Text] [Related]
9. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
[TBL] [Abstract][Full Text] [Related]
11. Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review.
Scholefield M; Unwin RD; Cooper GJS
Ageing Res Rev; 2020 Nov; 63():101152. PubMed ID: 32846222
[TBL] [Abstract][Full Text] [Related]
12. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
[TBL] [Abstract][Full Text] [Related]
13. The roles of epigenetic modifications in neurodegenerative diseases.
Qu W; Zhuang Y; Li X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):642-650. PubMed ID: 34986527
[TBL] [Abstract][Full Text] [Related]
14. The DNA Methylation in Neurological Diseases.
Younesian S; Yousefi AM; Momeny M; Ghaffari SH; Bashash D
Cells; 2022 Oct; 11(21):. PubMed ID: 36359835
[TBL] [Abstract][Full Text] [Related]
15. Methylation and acetylation in nervous system development and neurodegenerative disorders.
Mattson MP
Ageing Res Rev; 2003 Jul; 2(3):329-42. PubMed ID: 12726778
[TBL] [Abstract][Full Text] [Related]
16. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
18. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
Davis MY; Keene CD; Jayadev S; Bird T
J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
Atkinson A; Singleton AB; Steward A; Ince PG; Perry RH; McKeith IG; Fairbairn AF; Edwardson JA; Daly AK; Morris CM
Pharmacogenetics; 1999 Feb; 9(1):31-5. PubMed ID: 10208640
[TBL] [Abstract][Full Text] [Related]
20. [Neuroepigenetics: Desoxyribonucleic acid methylation in Alzheimer's disease and other dementias].
Mendioroz Iriarte M; Pulido Fontes L; Méndez-López I
Med Clin (Barc); 2015 May; 144(10):457-64. PubMed ID: 24907105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
